[Federal Register Volume 63, Number 113 (Friday, June 12, 1998)]
[Notices]
[Pages 32217-32219]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-15686]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 98070]
Evaluation of Violence Prevention Programs for High-Risk Youth
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 1998 funds for a cooperative agreement
program for the Evaluation of Violence Prevention Programs. This
program addresses the ``Healthy People 2000'' priority area of Violent
and Abusive Behavior.
The purpose of this cooperative agreement is to support the
implementation and evaluation of interventions which are designed to
prevent violence-related injuries among high-risk youth (ages 13-21).
For the purpose of this announcement, high-risk youth does not include
youth that are detained.
Applicants may propose to implement and evaluate interventions to
prevent injuries due to interpersonal youth (ages 13-21) violence. The
aim for these interventions is to reduce the risk of violence related
injury among high-risk youth and refers to impact assessment of efforts
to target youths (ages 13-21) who are in alternative schools, or have
been injured in a violent incident or have received treatment for a
violence related assault or trauma.
B. Eligible Applicants
Applications may be submitted by public and private nonprofit
organizations and by governments and their agencies; that is,
universities, colleges, research institutions, hospitals, other public
and private nonprofit organizations, and State and local governments or
their bona fide agents.
Note: Pub. L. 104-65, which became effective January 1, 1996,
states that an organization described in section 501(c)(4) of the
Internal Revenue Code of 1986 which engages in lobbying activities
shall not be eligible to receive Federal funds constituting an
award, grant (cooperative agreement), contract, loan, or any other
form.
C. Availability of Funds
Approximately $1,500,000 is available in FY 1998 to fund
approximately four awards. It is expected that the average award will
be $375,000 ranging from $350,000 to $400,000. It is expected that the
awards will begin on or about September 30, 1998 and will be made for a
12-month budget period within a project period of up to three years.
Funding estimates may change.
Non-competing continuation awards for new budget periods within an
approved project period are made on the basis of satisfactory
performance and availability of funds.
Funding Preferences
In making awards, priority consideration will be given to ensuring
geographic balance, a representative mixture of target groups,
diversity of intervention strategies, and settings. Priority will be
given to proposed projects evaluating efforts to reduce risk of
violence related injury among high-risk youth.
D. Cooperative Activities
In conducting activities to achieve the purpose of this program,
the recipient will be responsible for the activities under A.
(Recipient Activities), and CDC will be responsible for the activities
listed under B. (CDC Activities).
1. Recipient Activities
a. Develop and implement an intervention protocol.
b. Develop and pilot test data collection instruments.
c. Analyze data and interpret findings.
d. Establish an advisory committee (who represents the target
population) that will address issues related to violence to ensure
community engagement.
e. Develop collaborative relationships with voluntary, community-
based public and private organizations and agencies already involved in
preventing violence.
f. Compile and disseminate the results from the project.
2. CDC Activities
a. Collaborate on the development of the intervention protocol.
b. Provide technical assistance on the development and evaluation
of the data collection instruments.
c. Provide up-to-date scientific information about youth violence
prevention.
d. Assist in the transfer of information and methods developed in
these projects to other prevention programs.
E. Application Content
Use the information in the Cooperative Activities, Other
Requirements, Evaluation Criteria sections and the Errata Sheet
(Addendum III), included in the application package to develop the
application content. Your application will be evaluated on the criteria
listed, so it is important to follow them in laying out your program
plan.
The narrative should be no more than 30 double-spaced pages,
printed on one side, with one inch margins, and unreduced font (no
smaller than 10 cpi).
F. Submission and Deadline
Submit the original and five copies of PHS-398 (OMB Number 0925-
0001) and adhere to the instructions on the Errata Instruction Sheet
for PHS 398. Forms are in the application kit.
On or before AUGUST 13, 1998, submit to: Joanne Wojcik, Grants
Management Specialist, Grants Management Branch, Procurement and Grants
Office, Announcement 98070, Centers for Disease Control and Prevention
(CDC), 255 East Paces Ferry Road, NE., Room 300, Mailstop E-13,
Atlanta, GA 30305-2209.
If your application does not arrive in time for submission to the
independent review group, it will not be considered in the current
competition unless you can provide proof that you mailed it on or
before the deadline (i.e., receipt from U.S. Postal Service or a
commercial carrier; private metered postmarks are not acceptable).
G. Evaluation Criteria
Each application will be evaluated individually against the
following criteria by an independent reviewer group appointed by CDC.
Applicants will be evaluated according to the following criteria
(Maximum of 100 total points):
1. Intervention Plan (35 Points)
a. Target Group. The extent to which the target group is described
and access to the target population is demonstrated. The extent to
which the target group has a high incidence or prevalence of the risk
factors to be influenced by the proposed intervention and the extent to
which appropriate demographic and morbidity data are described. The
extent to which youth, who are the direct or indirect target group,
have a high incidence of interpersonal violence and violence-related
injuries, disabilities, and deaths. The extent to which the applicant
demonstrates a capability to achieve a sufficient level of
participation by the target group in order to evaluate the intervention
in an
[[Page 32218]]
unbiased fashion. In addition, the degree to which the applicant has
met the CDC/Agency for Toxic Substances and Disease Registry (ATSDR)
policy requirements regarding the inclusion of women, ethnic, and
racial groups in the proposed project. This includes:
i. The proposed plan for the inclusion of both sexes and racial and
ethnic minority populations for appropriate representation.
ii. The proposed justification when representation is limited or
absent.
iii. A statement as to whether the design of the study is adequate
to measure differences when warranted.
iv. A statement as to whether the plans for recruitment and
outreach for study participants include the process of establishing
partnerships with community(ies) and recognition of mutual benefits.
b. Intervention description. The extent to which the potential
effectiveness of the intervention is theoretically justified and
supported by epidemiologic, or social and behavioral research. The
extent to which the intervention is feasible and can be expected to
produce the expected results in the target group of interest. The
extent to which the intervention, its implementation, the development
of all necessary materials, and all necessary training are clearly
described. The extent to which the desired outcomes (e.g., behavioral
change, avoidance/prevention of injury, disability, or death) are
specified and definitions of measurable endpoints are provided. The
extent to which the setting in which the intervention is to be
implemented is clearly described and shown to be adequate for reaching
the target group and achieving the desired objectives. The status of
all necessary measurement instruments or training materials must be
described; if any of this material is not extant, methods and time
frames for their development must be described. Necessary collaborators
must be identified, and evidence of their ability and intention to
participate must be supplied. The extent to which the proposed goals
and objectives are clearly stated, time-phased, and measurable.
2. Evaluation Design and Analysis (35 Points)
The extent to which the evaluation design and the data analysis
plan are clearly described and are appropriate for the target group,
intervention, data collection opportunities, and proposed project
period. The extent to which the various threats to the validity of the
evaluation are recognized and addressed. The extent to which the
sampling methods, sample size estimates, power estimates, and attrition
of the participating population are clarified. The extent to which data
collection, data processing, and management activities are clearly
described. The extent to which the major phases of the project are
clearly presented and logically and realistically sequenced. The extent
to which the proposed goals and objectives are clearly stated, time-
phased, and measurable.
3. Project Management and Staffing Plan (10 Points)
The extent to which project management staff and their working
partners are clearly described, appropriately assigned, and possess
pertinent skills and experiences to conduct the project successfully to
completion. The extent to which the applicant has arranged to involve
appropriate researchers and other personnel who reflect the racial/
ethnic composition of the target group. The extent to which the
applicant or a full working partner demonstrates the capacity and
facilities to design, implement, and evaluate the proposed
intervention.
4. Collaboration (20 Points)
The extent to which the necessary partners are clearly described
and their qualifications and intentions to participate explicitly
stated. The extent to which the applicant provides proof of support
(e.g., letters of support and/or memoranda of understanding) for
proposed activities. The extent to which a full working partnership
between a community-based organization, a university or other academic
institution, and a State or local health department has been
established for applicants seeking funds for a 3 year project period.
Evidence must be provided that these funds do not duplicate already
funded components of ongoing projects.
5. Human Subjects (Not Scored)
If human subjects will be involved, how they will be protect, i.e.,
describe the review process which will govern their participation.
6. Proposed Budget (Not Scored)
The extent to which the budget request is clearly explained,
adequately justified, reasonable, sufficient for the proposed project
activities, and consistent with the intended use of the cooperative
agreement funds. Budgets should include costs for travel for two
project staff to attend two meetings per year in Atlanta with CDC
staff.
H. Other Requirements
1. Technical Reporting Requirements
Provide CDC with an original plus two copies of:
a. Semi-annual progress reports.
b. Financial status report, no more than 90 days after the end of
the budget period.
c. Final financial status report and performance report, no more
than 90 days after the end of the project period.
Send all reports to: Joanne Wojcik, Grants Management Specialist,
Grants Management Branch, Procurement and Grants Office, Centers for
Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE.,
Room 300, Mailstop E-13, Atlanta, GA 30305-2209.
Confidentiality of Records
All identifying information obtained in connection with the
provision of services to any person in any program that is being
carried out with a cooperative agreement made under this announcement
shall not be disclosed unless required by a law of a State or political
subdivision or unless written, voluntary informed consent is provided
by persons who received services.
1. Nonpersonal identifying, unlinked information, which preserves
the individual's anonymity, derived from any such program may be
disclosed without consent:
a. In summary, statistical, or other similar form, or
b. For clinical or research purposes.
2. Personal identifying information: Recipients of CDC funds who
must obtain and retain personal identifying information as part of
their CDC-approved work plan must:
a. Maintain the physical security of such records and information
at all times;
b. Have procedures in place and staff trained to prevent
unauthorized disclosure of client-identifying information;
c. Obtain informed client consent by explaining the risks of
disclosure and the recipient's policies and procedures for preventing
unauthorized disclosure;
d. Provide written assurance to this effect including copies of
relevant policies; and
e. Obtain assurances of confidentiality by agencies to which
referrals are made.
Assurance of compliance with these and other processes to protect
the confidentiality of information will be required of all recipients.
A Department of Health and Human Services (DHHS) certificate of
confidentiality may be required for some projects.
The following additional requirements are applicable to this
[[Page 32219]]
program. For a complete description of each, see Addendum I (included
in the application kit).
AR98-1 Human Subjects Requirements
AR98-2 Requirements for Inclusion of Women and Racial and Ethnic
Minorities in Research
AR98-9 Paperwork Reduction Act Requirements
AR98-10 Smoke-Free Workplace Requirements
AR98-11 Healthy People 2000
AR98-12 Lobbying Restrictions
AR98-13 Prohibition on Use of CDC Funds for Certain Gun Control
Activities
I. Authority and Catalog of Federal Domestic Assistance Number
This program announcement is authorized under Sections 391, 392,
393, and 394 [42 U.S.C. 280b, 280b-1, 280b-1a, and 280b-2] of the
Public Service Act, as amended. The Catalog of Federal Domestic
Assistance number is 93.136.
J. Where To Obtain Additional Information
The program announcement and application forms may be downloaded
from the Internet: www.cdc.gov (look under funding). You may also
receive a complete application kit by calling 1-888-GRANTS4. You will
be asked to identify the program announcement number and provide your
name and mailing address. A complete announcement kit will be mailed to
you.
Please refer to Program Announcement 98070 when you request
information.
If you have questions after reviewing the forms, for business
management technical assistance, contact: Joanne Wojcik, Grants
Management Specialist, Grants Management Branch, Procurement and Grants
Office, Announcement 98070, Centers for Disease Control and Prevention
(CDC), 255 East Paces Ferry Road, NE., Room 300, Mailstop E-13,
Atlanta, GA 30305-2209, telephone (404) 842-6535, E-mail address
jcw6@cdc.gov.
For program technical assistance, contact Wendy Watkins, Division
of Violence Prevention, National Center for Injury Prevention and
Control, Centers for Disease Control and Prevention (CDC), 4770 Buford
Highway, NE., Mailstop K-60, Atlanta, GA 30341-3724, telephone (770)
488-4646, E-mail address dmw7@cdc.gov.
Dated: June 8, 1998.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 98-15686 Filed 6-11-98; 8:45 am]
BILLING CODE 4163-18-M